ARCHIVES

Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs

This article is from The Cancer Letter archive.

Vol. 16 No. 34 | September 7, 1990

Download PDF Visit The Full Archive

Related Articles

NCI Clinical Alert Urges Patients To Seek Care From Specialists.

January 20, 2006

NCI Programs: Genetic Variations Discovered, Added to NCI Database

June 11, 1999

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

July 25, 2014

Duke’s Victor Dzau Named President of The Institute of Medicine

February 21, 2014

NCI Clinical Trials Working Group is looking for pragmatic solutions to improve cancer clinical trials system, Institute official says.

September 24, 2004

In Breif: Baltimore Developer Donates $10 Million To Univ. of Maryland Medical System

July 19, 1996